Europe Organoids Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Organoids Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Organoids Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 The organoid services market is experiencing rapid growth owing to the increasing demand for innovative screening services.

5.2 Market Opportunities

5.2.1 Increasing key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth

5.3 Future Trends

5.3.1 AI-driven automation can revolutionize organoid production and research workflows

5.4 Impact of Drivers and Restraints

6. Europe Organoids Market Regional Analysis

6.1 Europe Organoids Market Overview

6.2 Europe Organoids Market Revenue 2020-2030 (US$ Million)

6.3 Europe Organoids Market Forecast Analysis

7. Europe Organoids Market Analysis – by Organ Type

7.1 Intestine

7.1.1 Overview
7.1.2 Intestine: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Liver

7.2.1 Overview
7.2.2 Liver: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Stomach

7.3.1 Overview
7.3.2 Stomach: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Pancreas

7.4.1 Overview
7.4.2 Pancreas: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Lung

7.5.1 Overview
7.5.2 Lung: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Brain

7.6.1 Overview
7.6.2 Brain: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Kidney

7.7.1 Overview
7.7.2 Kidney: Europe Organoids Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Organoids Market Analysis – by Application

8.1 Development of Biology Disease

8.1.1 Overview
8.1.2 Development of Biology Disease: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Pathology of infectious Disease

8.2.1 Overview
8.2.2 Pathology of infectious Disease: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Regenerative Medicines

8.3.1 Overview
8.3.2 Regenerative Medicines: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Drug Discovery and Personalized Medicine

8.4.1 Overview
8.4.2 Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Drug Toxicity and Efficacy Testing

8.5.1 Overview
8.5.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Organoids Market Analysis – by Source

9.1 Pluripotent Stem Cell

9.1.1 Overview
9.1.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Organ Specific Adult Stem Cell

9.2.1 Overview
9.2.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Organoids Market – Europe Analysis

10.1 Europe

10.1.1 Europe Organoids Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Organoids Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Organoids Market Breakdown, by Organ Type
10.1.1.1.2 UK: Europe Organoids Market Breakdown, by Application
10.1.1.1.3 UK: Europe Organoids Market Breakdown, by Source

10.1.1.2 Germany: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Organoids Market Breakdown, by Organ Type
10.1.1.2.2 Germany: Europe Organoids Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Organoids Market Breakdown, by Source

10.1.1.3 France: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Organoids Market Breakdown, by Organ Type
10.1.1.3.2 France: Europe Organoids Market Breakdown, by Application
10.1.1.3.3 France: Europe Organoids Market Breakdown, by Source

10.1.1.4 Russia: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Organoids Market Breakdown, by Organ Type
10.1.1.4.2 Russia: Europe Organoids Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Organoids Market Breakdown, by Source

10.1.1.5 Italy: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Organoids Market Breakdown, by Organ Type
10.1.1.5.2 Italy: Europe Organoids Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Organoids Market Breakdown, by Source

10.1.1.6 Rest of Europe: Europe Organoids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Organoids Market Breakdown, by Organ Type
10.1.1.6.2 Rest of Europe: Europe Organoids Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Organoids Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Organoids Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Cellesce

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 definigen

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Hubrecht organoid technology

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 InSphero

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Merck KGaA

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 STEMCELL Technologies Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Thermo Fisher Scientific Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights